NCT00833976View on ClinicalTrials.gov

Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
High TriglyceridesHypercholesterolemiaSchizophreniaSchizoaffective DisorderBipolar Disorder
Interventions
DRUG

Lovaza

4 grams per day

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Massachusetts General Hospital

OTHER